HAL-01 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HAL-01 cell line is derived from the peripheral blood of a female adolescent with a diagnosis of acute lymphoblastic leukemia (ALL), specifically the L2 subtype. This cell line is particularly notable for containing the t(17;19)(q22;p13) chromosomal translocation, which results in the TCF3-HLF (E2A-HLF) fusion gene. This genetic feature is critical in the study of leukemia as it influences the behavior of leukemia cells, including aspects of their growth, differentiation, and response to therapies. The presence of the TCF3-HLF fusion gene in the HAL-01 cell line makes it an invaluable resource for oncological research, particularly for studies focused on the mechanisms of leukemogenesis and the development of targeted therapies for leukemia. The fusion protein encoded by this gene is involved in the regulation of gene transcription and has been associated with poor prognosis in patients, underscoring the importance of this cell line in therapeutic development and prognostic research in acute lymphoblastic leukemia. |
|---|---|
| Organism | Human |
| Tissue | B Cell Precursor Leukemia |
| Synonyms | HAL01, HAL-1 |
Characteristics
| Age | 17 years |
|---|---|
| Gender | Female |
| Morphology | Lymphoblast |
| Growth properties | Suspension |
Regulatory Data
| Citation | HAL-01 (Cytion catalog number 305140) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1242 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Doubling time | 48 hours |
| Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305140-240624 | Certificate of Analysis | 23. May. 2025 | 305140 |